BioNexus Gene Lab Corp. Bersetuju untuk Melabur RM 1.2 juta dalam Ascension Innovation (AISB) untuk Memajukan Inovasi Kesihatan Digital menerusi penerimaan AI dalam Penjagaan Kesihatan
April 19, 2024 17:36 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, April 20, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), peneraju global dalam diagnostik genomik dan teknologi penjagaan kesihatan, mengumumkan...
Millicom (Tigo) share repurchase activity
April 19, 2024 17:30 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, April 19, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 38,891 of its Swedish Depository...
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
April 19, 2024 17:30 ET
|
Celularity Inc.
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and...
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
April 19, 2024 17:28 ET
|
Wrap Technologies, Inc.
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 19, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
April 19, 2024 17:10 ET
|
ASLAN PHARMACEUTICALS LIMITED
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
Junee Limited Announces Closing of $8 Million Initial Public Offering
April 19, 2024 16:30 ET
|
Junee Ltd
Hong Kong, April 19, 2024 (GLOBE NEWSWIRE) -- Junee Limited (the “Company” or “Junee”), a provider of interior design, fit-out and maintenance services in Hong Kong, today announced the closing of...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
April 19, 2024 16:30 ET
|
Hepion Pharmaceuticals, Inc.
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 19, 2024 16:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...